In the BioHarmony Drug Report Database

"Preview" Icon

Olmesartan medoxomil

Benicar, Edarbi (olmesartan medoxomil) is a small molecule pharmaceutical. Olmesartan medoxomil was first approved as Benicar on 2002-04-25. It is used to treat diabetic nephropathies, heart failure, hypertension, and left ventricular dysfunction in the USA. It has been approved in Europe to treat hypertension. The pharmaceutical is active against type-1 angiotensin II receptor.

 

Trade Name

 

Edarbi
 

Common Name

 

olmesartan medoxomil
 

ChEMBL ID

 

CHEMBL1200692
 

Indication

 

diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction
 

Drug Class

 

Angiotensin II receptor antagonists

Image (chem structure or protein)

Olmesartan medoxomil structure rendering